166 related articles for article (PubMed ID: 9554881)
1. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K
J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881
[TBL] [Abstract][Full Text] [Related]
2. [The active conformation of teleocidins: design and synthesis of new active molecules].
Endo Y; Ohno M; Shudo K
Yakugaku Zasshi; 1994 Jul; 114(7):464-77. PubMed ID: 7932093
[TBL] [Abstract][Full Text] [Related]
3. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
Kozikowski AP; Wang S; Ma D; Yao J; Ahmad S; Glazer RI; Bogi K; Acs P; Modarres S; Lewin NE; Blumberg PM
J Med Chem; 1997 Apr; 40(9):1316-26. PubMed ID: 9135029
[TBL] [Abstract][Full Text] [Related]
4. Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams.
Endo Y; Yokoyama A
Bioorg Med Chem Lett; 2000 Jan; 10(1):63-6. PubMed ID: 10636245
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety.
Endo Y; Shimazu M; Fukasawa H; Driedger PE; Kimura K; Tomioka N; Itai A; Shudo K
Bioorg Med Chem Lett; 1999 Jan; 9(2):173-8. PubMed ID: 10021922
[TBL] [Abstract][Full Text] [Related]
6. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.
Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H
Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501
[TBL] [Abstract][Full Text] [Related]
7. Similar, potent tumor-promoting activity of all isomers of teleocidins A and B in a two-stage carcinogenesis experiment on the skin of CD-1 mice.
Fujiki H; Suganuma M; Ninomiya M; Yoshizawa S; Yamashita K; Takayama S; Hitotsuyanagi Y; Sakai S; Shudo K; Sugimura T
Cancer Res; 1988 Aug; 48(15):4211-4. PubMed ID: 3134123
[TBL] [Abstract][Full Text] [Related]
8. Artificial analogs of naturally occurring tumor promoters as biochemical tools and therapeutic leads.
Nakagawa Y
Biosci Biotechnol Biochem; 2012; 76(7):1262-74. PubMed ID: 22785480
[TBL] [Abstract][Full Text] [Related]
9. A receptor model for tumor promoters: rational superposition of teleocidins and phorbol esters.
Itai A; Kato Y; Tomioka N; Iitaka Y; Endo Y; Hasegawa M; Shudo K; Fujiki H; Sakai S
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3688-92. PubMed ID: 3131760
[TBL] [Abstract][Full Text] [Related]
10. Active conformation of a tumor promoter, teleocidin. A molecular dynamics study.
Kawai T; Ichinose T; Endo Y; Shudo K; Itai A
J Med Chem; 1992 Jun; 35(12):2248-53. PubMed ID: 1613749
[TBL] [Abstract][Full Text] [Related]
11. Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.
Wang S; Liu M; Lewin NE; Lorenzo PS; Bhattacharrya D; Qiao L; Kozikowski AP; Blumberg PM
J Med Chem; 1999 Sep; 42(18):3436-46. PubMed ID: 10479277
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies of the indole alkaloid tumor promoter teleocidins.
Irie K; Hagiwara N; Tokuda H; Koshimizu K
Carcinogenesis; 1987 Apr; 8(4):547-52. PubMed ID: 3103947
[TBL] [Abstract][Full Text] [Related]
13. [The active structure of tumor promoters].
Endo Y; Itai A; Shudo K; Fujiki H
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3365-75. PubMed ID: 3098181
[TBL] [Abstract][Full Text] [Related]
14. Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors.
Umezawa K; Weinstein IB; Horowitz A; Fujiki H; Matsushima T; Sugimura T
Nature; 1981 Apr; 290(5805):411-3. PubMed ID: 6261139
[TBL] [Abstract][Full Text] [Related]
15. Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin.
Jeffrey AM; Liskamp RM
Proc Natl Acad Sci U S A; 1986 Jan; 83(2):241-5. PubMed ID: 3079908
[TBL] [Abstract][Full Text] [Related]
16. Functions, Structures, and Engineering of the Teleocidin Biosynthetic Enzymes.
Mori T
Chem Pharm Bull (Tokyo); 2023; 71(3):188-197. PubMed ID: 36858523
[TBL] [Abstract][Full Text] [Related]
17. The effects of teleocidin and aplysiatoxin tumor promoters on epithelial tight junctions and transepithelial permeability: comparison to phorbol esters.
Mullin JM; McGinn MT; Snock KV; Imaizumi S
Carcinogenesis; 1990 Mar; 11(3):377-85. PubMed ID: 2311179
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of human monocyte oxidative burst and related cytotoxicity by tumor-promoting and non-tumor-promoting diterpene esters, indole alkaloids and polyacetate-type agents.
Keisari Y; Geva I; Flescher E; Goldin H; Lavie G
Int J Cancer; 1985 Oct; 36(4):467-72. PubMed ID: 3930412
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of protein kinase C activation by tumor promoters.
Nakamura H; Kishi Y; Pajares MA; Rando RR
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9672-6. PubMed ID: 2602368
[TBL] [Abstract][Full Text] [Related]
20. Activation of protein kinase C and specific phosphorylation of a Mr 90,000 membrane protein of promotable BALB/3T3 and C3H/10T1/2 cells by tumor promoters.
Chida K; Hashiba H; Sasaki K; Kuroki T
Cancer Res; 1986 Mar; 46(3):1055-62. PubMed ID: 3080229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
